Abstract:OBJECTIVE:To investigate the clinical experience and associated factors of extracorporeal membrane oxygenation(ECMO) for adult patients with severe acute respiratory distress syndrome (ARDS). METHODS:The clinical data of 58 adult patients with severe ARDS, which met the criteria for ECMO and treated in comprehensive intensive care unit of the Second Affiliated Hospital of Zhengzhou University from August 2012 to June 2015, were retrospectively collected and analyzed. The patients were divided into the ECMO group and the control group according to whether ECMO support was used. The ECMO group was further divided into the survival group and the non-survival group according to outcomes 3 months after the initiation of ECMO. The statistics software of SPSS 17.0 was used for data analysis. RESULTS:Of the 58 patients, 28 were treated with VV-ECMO. There were 22 males and 6 females, aged from 34 to 61 years, with a mean age of (49±8) years. Mean time of mechanical ventilation before ECMO therapy was(71±25) h. The main factors(the lowest PaO2/FiO2 and pH, the highest PEEP, PaCO2 and serum lactate level, the grade of APACHEⅡ, Murray and SOFA) between the ECMO group and the control group were not significantly different(all P>0.05). There were no significant differences in the factors before therapy(all P>0.05), except pH, heart rate (HR) and mean arterial pressure (MAP) between the ECMO survival group and the ECMO non-survival group. Compared with the factors at the same time point in the control group, those of the ECMO group were significantly improved after ECMO running 2 hours and 1 day (all P<0.05). Most factors of the ECMO group were also significantly improved after ECMO running 2 days (all P<0.05) except MAP; the MAP of the ECMO non-survival group being lower than the control group (t=2.433, P=0.019). After ECMO running 3 days, most factors of the ECMO survival group were better than those of the control group (all P<0.05) except MAP, but most factors between the ECMO non-survival group and the control group were not significantly different (all P>0.05), while the serum lactate level was higher (t=-3.156, P=0.003) and the MAP lower (t=3.578, P=0.001). Eighteen patients were successfully weaned from ECMO, and 15 patients survived to 3 months without severe disability. The survival rate between the ECMO group and the control group was not significantly different(53.57% and 43.33%, χ(2)=0.608, P=0.436). CONCLUSIONS:Our experience suggests that VV-ECMO may be an effective life support treatment for severe ARDS and should be used as early as possible when the ECMO criteria are met. Indexes such as age, time of mechanical ventilation before ECMO therapy, time between disease onset and ECMO therapy, HR, MAP, serum lactate level and serum procalcitonin level, may be the risk factors for prognosis.

Ultra-protective ventilation combined with V-V ECMO has a preferable therapeutic effect on Acute Respiratory Distress Syndrome: An experimental study in aged Beagle dogs

Effect of Individualized Protective Pulmonary Ventilation Strategy on Pulmonary Ventilation in Elderly Patients under General Anesthesia

Pulmonary inflammation decreases with ultra-protective ventilation in experimental ARDS under VV-ECMO: a positron emission tomography study

[The Effects of Positive End-Expiratory Pressure Targeting Optimal Oxygenation on Local Gas Distribution and Inflammation in Dogs with Acute Respiratory Distress Syndrome].

Venovenous Extra-Corporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome: a Matched Cohort Study

Establishment of an inflammation-related acute lung injury/acute respiratory distress syndrome rat model supported by venovenous extracorporeal membrane oxygenation

Randomized controlled trial of ultra-protective vs. protective ventilation strategy in veno-arterial extracorporeal membrane oxygenation patients with refractory cardiogenic shock: a study protocol for the ultra-ECMO trial

[The Clinical Analysis of Extracorporeal Membrane Oxygenation for Adult Severe Acute Respiratory Distress Syndrome].

Effects of Different Modes of Artificial Ventilation on Lung Injury in Dog Model of Acute Respiratory Distress Syndrome

Effects of dynamic ventilatory factors on extrapulmonary inflammatory response and function of extrapulmonary organs in a dog model of acute respiratory distress syndrome

Effects of Positive End-Expiratory Pressure Ventilation via Different Tidal Volume on Dogs with Oleic Acid-Induced Acute Lung Injury

Effects of ECMO on Plasma Cytokines in Dogs with Acute Lung Injury

Effects Of Dynamic Ventilatory Factors On Ventilatorinduced Lung Injury In Acute Respiratory Distress Syndrome Dogs

Improving oxygenation in severe ARDS treated with VV-ECMO: comparative efficacy of moderate hypothermia and landiolol in a swine ARDS model

Effect of Setting High APRV Guided by Expiratory Inflection Point of Pressure-Volume Curve on Oxygen Delivery in Canine Models of Severe Acute Respiratory Distress Syndrome

Mechanical Ventilation during Extracorporeal Membrane Oxygenation in Patients with Acute Severe Respiratory Failure

The Application of Individualized Ventilation Strategies in Acute Respiratory Distress Syndrome

Extracorporeal membrane oxygenation improves survival in a novel 24-hour pig model of severe acute respiratory distress syndrome.

Effect of Protective Ventilation and Open Lung Strategy on Extravascular Lung Water in Rabbits with Acute Respiratory Distress Syndrome

Effect of prone position ventilation and sustained inflation on gas exchange in dogs with ARDSexp and ARDSp

Removal of Mechanical Ventilation During Veno-Venous ECMO May Improve Outcome of Patients with Acute Respiratory Failure Due to Adult Community-Acquired Pneumonia